LEVOCETIRIZINE Drug Patent Profile
✉ Email this page to a colleague
When do Levocetirizine patents expire, and what generic alternatives are available?
Levocetirizine is a drug marketed by Apotex, Chartwell Molecular, Padagis Us, Taro, Dr Reddys, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Granules, Hetero Labs Ltd Iii, Ipca Labs Ltd, Macleods Pharms, Micro Labs Ltd India, Perrigo R And D, Sankalp Lifecare, Sciegen Pharms, Sun Pharm, Sun Pharm Inds Ltd, Synthon Bv, Teva Pharms, and Us Antibiotics. and is included in twenty-four NDAs.
The generic ingredient in LEVOCETIRIZINE is levocetirizine dihydrochloride. There is one drug master file entry for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levocetirizine
A generic version of LEVOCETIRIZINE was approved as levocetirizine dihydrochloride by SYNTHON BV on November 26th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVOCETIRIZINE?
- What are the global sales for LEVOCETIRIZINE?
- What is Average Wholesale Price for LEVOCETIRIZINE?
Summary for LEVOCETIRIZINE
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 24 |
| Drug Prices: | Drug price information for LEVOCETIRIZINE |
| Drug Sales Revenues: | Drug sales revenues for LEVOCETIRIZINE |
| DailyMed Link: | LEVOCETIRIZINE at DailyMed |
US Patents and Regulatory Information for LEVOCETIRIZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | SOLUTION;ORAL | 202915-001 | Aug 21, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sciegen Pharms | LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | TABLET;ORAL | 203646-001 | Sep 9, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hetero Labs Ltd Iii | LEVOCETIRIZINE HYDROCHLORIDE | levocetirizine dihydrochloride | SOLUTION;ORAL | 210914-001 | Apr 1, 2019 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
